In agreement with this observation, Kdm8 and KDM8 knockdown in multiple murine and human PDA cell lines significantly increased sensitivity to the KRASG12D inhibitor MRTX1133 (Figures S6H and S6I). The gene discussed is KDM8; the disease is Patent ductus arteriosus.